Seasonal Influenza Vaccine for 65 and Older

The U.S. Food and Drug Administration approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

Individuals in this age group are at highest risk for seasonal flu complications, which may result in hospitalization or death. Annual vaccination remains the best protection from influenza, particularly for people 65 and older. In clinical trials, Fluzone demonstrated an enhanced immune response compared with Fluzone in individuals in the same age grouping.

Researchers mentioned that as people age, their immune systems typically become weaker. This is the first flu vaccine used at a higher dosage to induce stronger immune response intended to better protect the elderly against seasonal flu viruses.

Staff – Everythingantiaging.com

Browse our great selection of affordable immune boosting supplements now at www.everythingantiaging.com